Eurazeo-healthcare https://en.newsroom.eurazeo.com/ en Thu, 02 Jul 2026 10:21:29 +0200 Kurma Partners, a member of the Eurazeo group and a shareholder of Memo Therapeutics AG, announces the sale of the biotech company to IPSEN for an amount that could reach up to €700 million. https://en.newsroom.eurazeo.com/news/kurma-partners-a-member-of-the-eurazeo-group-and-a-shareholder-of-memo-therapeutics-ag-announces-the-sale-of-the-biotech-company-to-ipsen-for-an-amount-that-could-reach-up-to-eur700-million-0ee83-52e2c.html https://en.newsroom.eurazeo.com/0ee83

]]> Thu, 02 Jul 2026 10:21:29 +0200 Kurma Partners, a Eurazeo group company, closes €215 million Biofund IV https://en.newsroom.eurazeo.com/news/kurma-partners-an-eurazeo-group-company-closes-eur215-million-biofund-iv-c5586-52e2c.html https://en.newsroom.eurazeo.com/c5586

]]> Thu, 23 Apr 2026 14:30:17 +0200 Kurma Partners, a member of the Eurazeo group and founding investor of ImCheck therapeutics, announces the sale of the biotech company to Ipsen for up to €1 billion https://en.newsroom.eurazeo.com/news/kurma-partners-membre-du-groupe-eurazeo-et-actionnaire-fondateur-d-imcheck-annonce-la-cession-de-la-biotech-a-ipsen-pour-un-montant-pouvant-atteindre-1-milliard-d-euros-2dbc2-52e2c.html https://en.newsroom.eurazeo.com/2dbc2

]]> Wed, 22 Oct 2025 07:30:03 +0200 Crédit Mutuel Equity, Eurazeo, and Bpifrance join forces with BNP Paribas Développement to succeed Ardian in supporting the family-owned Proteor group https://en.newsroom.eurazeo.com/news/credit-mutuel-equity-eurazeo-and-bpifrance-join-forces-with-bnp-paribas-developpement-to-succeed-ardian-in-supporting-the-family-owned-proteor-group-31483-52e2c.html https://en.newsroom.eurazeo.com/31483

]]> Mon, 22 Sep 2025 17:45:01 +0200 Eurazeo acquires the remaining capital of Kurma Partners, an asset management company specialising in medical innovation and biotechnology https://en.newsroom.eurazeo.com/news/eurazeo-acquires-the-remaining-capital-of-kurma-partners-an-asset-management-company-specialising-in-medical-innovation-and-biotechnology-49638-52e2c.html https://en.newsroom.eurazeo.com/49638

]]> Wed, 30 Apr 2025 10:00:00 +0200 Eurazeo participates in Germitec’s eur 29 million series B fundraising https://en.newsroom.eurazeo.com/news/eurazeo-participates-in-germitecs-eur-29-million-series-b-fundraising-7a07c-52e2c.html https://en.newsroom.eurazeo.com/7a07c

]]> Wed, 12 Feb 2025 10:00:00 +0100 Kurma Partners achieves first close of new eur 250 million Biofund IV https://en.newsroom.eurazeo.com/news/kurma-partners-achieves-first-close-of-new-eur-250-million-biofund-iv-7dda7-52e2c.html https://en.newsroom.eurazeo.com/7dda7

]]> Thu, 03 Oct 2024 10:00:00 +0200 Eurazeo and Kurma Partners invest in the €93 million financing of Pantera https://en.newsroom.eurazeo.com/news/eurazeo-and-kurma-partners-invest-in-the-eur-93-million-financing-of-pantera-e1e93-52e2c.html https://en.newsroom.eurazeo.com/e1e93

]]> Wed, 11 Sep 2024 10:00:00 +0200 Eurazeo, new shareholder in Moria alongside its historic sponsor Naxicap Partners https://en.newsroom.eurazeo.com/news/eurazeo-new-shareholder-in-moria-alongside-its-historic-sponsor-naxicap-partners-91c7a-52e2c.html https://en.newsroom.eurazeo.com/91c7a

]]> Thu, 05 Sep 2024 10:00:00 +0200 The Nov Santé Actions Non Cotées fund invests in Oncodesign Services https://en.newsroom.eurazeo.com/news/the-nov-sante-actions-non-cotees-fund-invests-in-oncodesign-services-eefd1-52e2c.html https://en.newsroom.eurazeo.com/eefd1

]]> Tue, 23 Jan 2024 10:00:00 +0100 The Nov Santé Actions Non Cotées fund invests in Kinvent https://en.newsroom.eurazeo.com/news/the-nov-sante-actions-non-cotees-fund-invests-in-kinvent-66ca9-52e2c.html https://en.newsroom.eurazeo.com/66ca9

]]> Thu, 18 Jan 2024 10:00:00 +0100